Skip to content
Colorectal Cancer Clinical Trials

Pennsylvania

Colorectal cancer clinical trials in Pennsylvania

91 colorectal cancer studies are recruiting participants at sites in 61 cities across Pennsylvania as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Pennsylvania by city

Cities with the most studies recruiting right now.

Every Pennsylvania city with a recruiting study

Philadelphia (48), Pittsburgh (37), Allentown (10), Danville (10), Hazleton (8), Hershey (8), Lewisburg (8), Wilkes-Barre (8), Bethlehem (7), East Stroudsburg (6), York (6), Chadds Ford (4), Dickson City (4), Pottsville (4), Scranton (4), Lebanon (3), Altoona (2), Butler (2), Chambersburg (2), Cranberry Township (2), Easton (2), Ephrata (2), Erie (2), Gettysburg (2), Indiana (2), Jefferson Hills (2), Monroeville (2), New Castle (2), Phoenixville (2), Seneca (2), West Reading (2), Wexford (2), Wynnewood (2), Beaver (1), Carlisle (1), Doylestown (1), Farrell (1), Greensburg (1), Harrisburg (1), Johnstown (1), Lancaster (1), Lewistown (1), McKeesport (1), Meadowbrook (1), Mechanicsburg (1), Moon Township (1), N. Huntingdon (1), Natrona Heights (1), Penn Wynne (1), Pottstown (1), Quakertown (1), Reading (1), Selinsgrove (1), Sellersville (1), State College (1), Stroudsburg (1), Uniontown (1), Washington (1), West Chester (1), Williamsport (1), Willow Grove (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Pennsylvania

Basic details from each study's public record (the 12 most recently updated of 91). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Allentown · Erie · Jefferson Hills · and 4 more U.S. locations
    Registry record
    NCT05863195 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Hershey
    Registry record
    NCT06324357 · updated
  3. Decision Counseling and Follow-up for Shield+ Patients

    • Observational
    • Ages 45 to 75
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Philadelphia
    Registry record
    NCT07620535 · updated
  4. Shield Post-Approval Study Protocol

    • Observational
    • Ages 45 to 81
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Altoona · Philadelphia · Pottstown
    Registry record
    NCT06880055 · updated
  5. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Easton · Pittsburgh
    Registry record
    NCT06997497 · updated
  6. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Recruiting in
    Philadelphia
    Registry record
    NCT07458347 · updated
  7. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Philadelphia
    Registry record
    NCT07020221 · updated
  8. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Allentown · Bethlehem · Chadds Ford · and 2 more U.S. locations
    Registry record
    NCT07018869 · updated
  9. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Recruiting in
    Danville · Hazleton · Lewisburg · and 6 more U.S. locations
    Registry record
    NCT03998202 · updated
  10. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Lebanon · Philadelphia · Pittsburgh · and 1 more U.S. location
    Registry record
    NCT07228832 · updated
  11. Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Allentown
    Registry record
    NCT04165772 · updated
  12. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Allentown · Bethlehem · Danville · and 10 more U.S. locations
    Registry record
    NCT05080673 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call